Anti-Ro/SS-A and anti-La/SS-B antibodies;Anticuerpos anti-Ro/SS-A y anti-La/SS-B

Revista Espanola de Reumatologia

Volumn 23, Issue 9, 1996, Pages 362-368

  López Longo, Francisco Javier ^a   Moreno, Alonso Carlos ^b   González, Carlos Manuel ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; RIBONUCLEOPROTEIN ANTIBODY;

AUTOIMMUNITY; DIAGNOSIS; HUMAN; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030460073     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Clark GM, Reichlin M, Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J Immunol 1969; 102 117122
2. Mattioli M. Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Arthritis Rheum 1974; 17 421-429
3. Aspaugh MA, Tan EM. Antibodies to cellular antigens in Sjögren's syndrome. J Clin Invest 1975; 55: 1.067-1 073
4. Akizuki M, Powers R, Holman HR. A soluble acidic protein of the cell nucleus which reacts with serum from patients with systemic lupus erythematosus and Sjogren's syndrome. J Clin Invest 1977; 59: 264-271
5. Alspaugh MA, Maddison P. Resolution of the identity of cer-tain antigen-antibody systems in systemic lupus erythematosus and Sjogren's syndrome an interlaboratory collaboration. Arthritis Rheum 1979; 22- 796-798
6. Lerner MR, Boyle JA, Hardin JA et al. Two novel classes of small RNA proteins detected by antibodies associated with lupus erythematosus. Science 1981; 211 400-402.
7. Boire G, Craft J. Human Ro ribonucleoprotein particles cha-racterization of native structure and stable association with the La polypeptide. J Clin Invest 1990; 85: 1.182-1.190
8. Rader MD, O'Brien C, Liu Y, Harley JB, Reichlin M. Heterogeneity of the Ro/Ss-A antigen. Different molecular forms in lymphocytes and red blood cells. J Clin Invest 1989. 83: 1.293-1.298
9. Wolin SL, Steitz JA. The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic proteins and its binding site on the Ro RNAs. Proc Natl Acad Sci USA 1984; 81 1.9962.000
10. Bcn-Chetrit E, Chan EKL, Sullivan KF. Tan EM: A 52 KD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 1988; 167- 1 560-1 571.
11. Itoh K, Itoh Y, Frank MB. Protein heterogeneity in the human Ro/SSA ribonucleoproteins The 52 and 60 kD Ro/SSA autoantigens are encoded by separate genes J Clin Invest 1991:87: 177-186.
12. Boire G, Gendron M, Monast N, Bastin B. Ménard HA. Purification of antigenically intact Ro ribonucleoproteins: biochemical and immunological evidence that the 52 KD proteins is not a Ro protein Clin Exp Immunol 1995; 100: 489-498
13. Chambers JC. Keene JD. Isolation and analysis of cDNA clones expressing human lupus La antigen Proc Natl Acad Sei USA 1985, 82: 2.115-2.119
14. Maddison PJ, Skinner RP, Vlachoyiannopoulos P et al. Antibodies to nRNP, Sm, Ro (SS-A) and la (SS-B) detected by ELISA: Their specificity and interrelationship in connective tissue disease sera Clin Exp Immunol 1985; 62 337-345
15. Topfer F. Gordon T, McCluskey J Intra-and intermolecular spreading of autoimmunity involving the nuclear self-antigens La(SS-B) and Ro(SS-A). Proc Natl Acad Sci USA 1995: 92: 875-879.
16. Zimmermann Ch, Steiner G, Hassfeld W, Graninger W, Smolen J Fine specificity of anti-Ro/SS-A autoantibodies and clinical manifestations in SLE patients [resumen] Arthritis Rheum 1992, 35 (Supl) 302
17. López-I.ongo FJ, Rodríguez-Mahou M, Escalona M et al. Heterogeneity of the anti-Ro(SS-A) response in rheumatic diseases. J Rheumatol 1994: 21: 1 450-1 456.
18. Slobbe RL, Pruijn GJM. Damen WGM, Van der Kemp JWCM, Van Venrooij WJ. Detection and occurrence of the 60 and 52 kD Ro (SS-A) antigens and of autoantibodies against these proteins. Clin Exp Immunol 1991, 86 99-105
19. Boire G, López-Longo FJ. Lapointe S. Ménard HA. Sera from patients with autoimmune disease recognize conformational determinants on the 60 kD Ro/SS-A protein Arthritis Rheum 1991; 34: 722-730.
20. Ben-Chetnt E. The molecular basis of the SS-A/Ro antigens and the clinical significance of their autoantibodies Br J Rheumatol 1993, 32: 396-402.
21. Barakat S, Meyer O. Torterotot F et al IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60 kD SS-A/Ro protein Chn Exp Immunol 1992. 89 38-45
22. Tsuzaka K, Ogasawara T, Tojo T et al Relationship between auroantibodies and clinical parameters in Sjögren s syndrome. Scanid J Rheumatol 1993: 22 1-9.
23. Bozic B, Pruijn GJ. Rozman B, Van Venrooij WJ: Sera from patients with rheumatic disease recongnize different epitope regions on the 52 kD Ro/SS-A protein. Clin Exp Immunol 1993, 94: 227-235.
24. Gordon T, Mavrangelos C, McCluskey J Restricted epitope recognition by precipitin-negative anti-La/SS-B-positive sera Arthritis Rheum 1992; 35: 663-666.
25. Tzioufas AG, Giannaki E, Sakarellos-Daitsiotis M, Routsias JG, Sakarellos K, Moutsopoulos HM. Epitope mapping of La/SS-B autoantigen using synthetic peptides: disease specific recognition of main antigenic determinants [resumen]. Rheum Eur 1995; 24 (Supl 3): 111.
26. Bell DA, Maddison PJ Serological subset in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980. 23: 1.268-1.273.
27. Sontheimer RD, Maddison PJ, Reichlin M, Jordan R, Stasny P, Gilliam JN. Serologie and HLA-associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982; 97; 664-671.
28. Ahearn JM, Provost TT, Dorsh C, Stevens MB, Bias WB, Arnett FC Interrelationship of HLA-DR, MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 1982; 25; l. 031-l.040
29. Hamilton RG, Harley JB, Bias WW et al Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31496-505.
30. Watson RM, Lane AT. Barrett NK, Bias WB, Arnett FC, Provost TT Neonatal lupus erythematosus: a clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 1984; 63 362-378.
31. Provost TT. Arnett FC, Reichlin M Homozygous C2Deficiency, lupus erythematosus and anti-Ro/SS-A antibodies. Arthritis Rheum 1983; 26 1.279-1.282
32. Reveille JD, McLeod MJ. Whittington K, Arnett FC. Specific aminoacid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro(SSA)/La(SS-B) autoantibody reponses J Immunol 1991, 146: 3.871-3.876,
33. Meilof JF, Bantjes I, De Jong J, Van Dam AP, Smeenk RJT The detection of anti-Ro(SS-A) and anti-Ro(SS-B) antibodies. A comparison of counterimmunoelectrophoresis with immunoblot. ELISA and RNA-precipitation assays J Immunol Methods 1990, 133: 215-226.
34. Manoussakis MM, Kistis KG, Liu X, Aidinis V, Guialis A, Moutsopoulos HM. Detection of anti-Ro(SS-A) antibodies in autoimmune diseases comparison of five methods. Br J Rheumatol 1993; 32 449-455
35. Tsuzaka K, Fujii T, Akizuki M et al. Clinical significance of antibodies to native or denatured 60 kD or 52 kD Ro/SS-A proteins in Sjogren's syndrome. Arthritis Rheum 1994; 37: 8892.
36. Ben-Chetrit E, Fox RI, Tan EM Dissociation of immune responses to the SS-A/Ro 52 kD and 60 kD polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 1990; 33 349-355
37. Boire G, Mćnard HA Detection of autoantibodies to the SS-A; Ro antigen reply [carta] Arthritis Rheum 1992; 35: 1 111-1 112.
38. Zhang F. Kunen BT, Harley JB, Scofield RH. Development of the humoral autoantibody response to 60 kD Ro in patients with systemic lupus erylhematosus [resumen] Arthritis Rheum 1994; 37: 173
39. Simmons-O'Brien E, Chen S, Watson R et al One hundred anti-Ro/SS-A antibody positive patients: a 10 year follow-up. Medicine (Baltimore/ 1995. 74 109-130.
40. Maddison PJ, Provost IT. Reichlin M Serological findings in patients with ANA-negaiive systemic lupus erythematosus Medicine (Baltimore) 1981, 60: 87-94
41. 4l Tan EM Antmuclear antibodies Diagnostic markers for autoimmune diseases and probes for cell biology Adv Immunol 1989. 44: 93-151
42. Harley JB. Alexander EL. Bias WB et al Anli-Ro(SS-A) and anti-La(SS-B) in Sjogren's syndrome. Arthritis Rheum 1986; 29. 196-206.
43. Bernstein RM Bunn CC, Hughes AM, Francoeur AM, Mathews MB. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med 1984; 2: 105-120.
44. Juby A, Johnston C, Davis P. Specificity, sensitivity and diagnostic predictive value of selected laboratory generated autoantibody profiles in patients with connective tissue diseases. J Rheumatol 1991; 18 354-358.
45. Scopelitis E, Biundo JJ, Alspaugh MA Anti-SS/A antibody and other antinuclear antibodies in systemic lupus erythematosus. Arthritis Rheum 1980, 23: 287-293.
46. Font J. Pallarés L. Cervera R et al Lupus eritematoso sistémico: estudio clínico e inmunológico de 300 pacientes Med Clin (Barc) 1993, 100: 601-605
47. Martinez-Lavin M, Vaughan JH. Tan EM. Autoantibodies and the spectrum of Sjögren's syndrome Ann Intern Med 1979, 91: 185-190
48. Williamson GG, Pennebaker J, Boyle JA Clinical characteristics of patients with rheumatic disorders who possess antibodies against RNP particles Arthritis Rheum 1983. 26 509-514.
49. Hirakata M, Mimori T, Akizuki M, Craft J Hardin JA. Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992; 35 449-456
50. De Rooij DJ, Van de Putte LB, Habets WJ, Verbeek AL, Van Venrooij WJ The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Scand J Rheumatol 1988; 17: 353-364
51. Froelich CJ. Wallman J, Skosey SL, Teodorescu M Clinical value of an integrated E1.1SA system for the detection of 6 autoantibodies (ss-DNA. ds-DNA. Sm, RNP. Sm. SS-A and SS-B). J Rheumatol 1990, 17: 192-200
52. Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M The autoantibody response to Ro/SS-A in cutaneous lupus crythematosus Arch Dermatol 1994, 130 1 262-1.268
53. Callen JP, Klein J Subacute cutaneous lupus erythematosus Clinical, scrologic, immunogenetic and therapeutic considerations in seventy-two patients Arthritis Rheum 1988; 31. 1 007-1.013
54. Scott JS, Maddison PJ, Taylor PV. Esscher E, Scott O, Skinner RP Connective tissue disease, antibodies to ribonucleoprotein and congenital heart block N Engl J Med 1983: 309. 209-212.
55. Sestak A, Harley J, Yoshida S, Reichlin M. Lupus/ Sjögren's autoantibodies specificities in sera with paraproteins J Clin Invest 1987, 80: 138-144
56. Argov S, Jaffe CL, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients infected with leishmama. Clin Exp Immunol 1989. 76: 190-197.
57. Rodríguez-Mahou M, López-Longo FJ, Lapointe N et al Autoimmune phenomena in children with Human Immunodeficiency Virus Infection and Adquired Immunodeficiency Syndrome Acta Pediatr 1994: 400 (Supl): 31-34
58. Wasicek CA, Reichlin M Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982; 69. 835-843
59. Alexander EL, Arnett FC, Provost TT. Stevens MB. Sjogren's syndrome association of anti-Ro (SS-A) antiodies with vasculitis, hematologie abnormalities, and serologic hyperreactivity. Ann Intern Med 1983, 98 155-159.
60. Alexander EL, Ranzenbach MR. Kumar AJ et al. Anti-Ro (SS-A) autoantibodies in central nervous system disease associated \vith Sjogren's syndrome, clinical, neuroimaging and angiographie correlations. Neurology 1994; 44 899-908
61. Chailes PJ. Foster H, Shattles W, Griffiths I. Maini RN. Serological profiles of antibodies to Ro and La in primary Sjogren's syndrome: a marker for clinical subsets ]resumen] Hungarian Rheumatology 1991. 32 341
62. Moutsopoulos HM, Klippel JH, Pavlidis N et al Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythemacosus. Arthritis Rheum 1980. 23: 36-40.
63. Delpech A, Gilbert D, Daliphard S, Le Loet X, Godin M. Tron F. Antibodies to Sm. RNP and SS-B detected by solid-phase ELISAs using, recombinant antigens: a comparison study with countenmmunoelectrophoresis and immunoblotung. J Clin Lab Anal 1993; 7: 197-202.
64. Maddison PJ. Reichlin M Deposition of antibodies to a soluble evtoplasmic antigen m the kidneys of patients with systemic lupus erythematosus Arthritis Rheum 1979: 22. 858-863.
65. Lee LA, Coulter S, Norris DA, Weston WL. An animal model for studying transplacental passage and ttssue deposition of antibody in neonatal lupus J Invest Dermatol 1989, 84: 488492.
66. Reichlin M, Van Venrooij WJ Autoantibodies to the U-RNP particles relationship to clinical diagnosis and nephritis Clin Exp Iinmunol 1991. 83' 286-290
67. Atkinon JC, Travis WD, Slocum L. Ebbs VCL, Fox PC. Serum anti-SS-B La and IgA-rhcumatoid factor are markers of salivary gland disease activity in primary Sjogren's syndrome Arthritis Rheum 1992, 35 1 368-1 372
68. Le Feber WP, Noms DA, Ryan SR et al Ultraviolet light induces expression of selected nuclear antigens on cultured human keratinocytes. [Clin Invest 1984, 74 1.545-1 549
69. Noms DA, Ryan SR, Fritz KA et al. The role of RNP, Sm and SS Ro-specific antisera from patients with lupus erythematosus in inducing ADCC of targets coated with nonhistone nuclear antigens. Clin Immunol Immunopathol 1984; 17: 249254
70. Buvon JP, Winchester R. Congenital complete heart block A human model of passively adquirecl autoimmune injury Arthritis Rheum 1990: 33. 609-614.
71. Alexander E. Buyon JP. Provost TT et al Anti-Ro SS-A antibodies in the patophysiology of congenital heart block in neonatal syndrome, an experimental model Arthritis Rheum 1992, 35 176-189.